Computationally designed phospholamban-SERCA for rectifying diabetic cardiomyopa
计算设计的受磷蛋白-SERCA用于治疗糖尿病心肌病
基本信息
- 批准号:8526815
- 负责人:
- 金额:$ 4.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-30 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATP phosphohydrolaseAdrenergic AgentsAffinityAmericanArrhythmiaBindingCa(2+)-Transporting ATPaseCalciumCalcium SignalingCardiacCardiac MyocytesCell modelCell physiologyCellsCenters for Disease Control and Prevention (U.S.)CharacteristicsComplexDataDefectDevelopmentDiabetes MellitusDiseaseDown-RegulationEpidemicFunctional disorderGoalsHealthHeart failureHomeostasisLeadMechanicsModelingModificationMolecularMolecular ProbesMuscle CellsMutationMyopathyOrangesOryctolagus cuniculusPathologyPathway interactionsPersonsPhenotypePhosphorylationPlayProtein KinasePumpRegulationRestRiskRoleRyanodine Receptor Calcium Release ChannelSarcoplasmic ReticulumSignal PathwaySignal TransductionSimulateStagingSystemTestingTherapeuticVentricularadrenergicbasecalmodulin-dependent protein kinase IIdesigndiabeticdiabetic cardiomyopathyinhibitor/antagonistinsightmathematical modelmolecular dynamicsmolecular scalephospholambanpublic health relevancereconstructionsimulationsmall moleculestemtherapeutic developmentuptake
项目摘要
DESCRIPTION (provided by applicant): Diabetes is an epidemic afflicting 25 million Americans and nearly 350 million persons world-wide. Diabetic cardiomyopathy (DCM) is a cardiac pathology presented in many of those afflicted by diabetes, which contributes to a disproportionate risk of heart failure. Heart failure in part stems from the dysfunctional regulatin of calcium (Ca2+) in cardiomyocytes. Ca2+ plays a critical role in the excitation and mechanical activity of cardiac cells and pathogenic alterations its signaling pathways increase the propensity for dangerous arrhythmias. Reduced sarcoplasmic reticulum (SR) Ca2+ content is a major contributor to DCM, and deficient Ca2+ uptake by the sarcoplasmic reticulum Ca2+ ATPase (SERCA) is partially at fault. The complex interplay between SERCA, its endogenous inhibitor, phospholamban (PLB), and protein kinases in regulating SR content and Ca2+ signaling complicates our understanding of DCM. To this end, species- and DCM-specific mathematical models of Ca2+ signaling in cardiomyocytes enable the integration of diverse experimental probes of molecular-and cellular-level aspects of pathological PLB/SERCA function. In Aim 1, the molecular basis of PLB binding to SERCA and identify targets for increasing ATPase activity will be explored using molecular dynamics simulations. In Aim 2, the impact of enhanced SERCA uptake in restoring normal cardiac function, including the effects of CaMKII and beta-adrenergic stimulation, using a cellular model of Ca2+ signaling and phosphorylation will be examined. In the short term, successful completion of these aims will yield insight into precise control of SERCA by tuning the PLB interaction, thereby potentially yielding small-molecule targets to treat diabetic cardiomyopathy. In the long term, molecular and cellular insight into dysfunctional calcium regulation provide a mechanistic insight into diabetic cardiomyopathy and heart failure, in general.
描述(由申请人提供):糖尿病是一种流行病,全球2500万美国人和近3.5亿人。糖尿病性心肌病(DCM)是在许多受糖尿病折磨的患者中提出的心脏病理学,导致心力衰竭的不成比例风险。心力衰竭部分源自心肌细胞中钙(Ca2+)功能失调的调节素。 Ca2+在心脏细胞的激发和机械活性和致病性改变中起着至关重要的作用,其信号通路会增加危险心律不齐的倾向。减少的肌浆网(SR)Ca2+含量是DCM的主要因素,而肌浆网Ca2+ ATPase(SERCA)的Ca2+摄取不足是部分故障。 SERCA,其内源性抑制剂,磷脂(PLB)和蛋白激酶在调节SR含量和Ca2+信号传导中的复杂相互作用使我们对DCM的理解变得复杂。为此,心肌细胞中Ca2+信号传导的物种和DCM特异性数学模型可以整合病理PLB/SERCA功能的分子和细胞级方面的各种实验探针。在AIM 1中,将使用分子动力学模拟探索PLB与SERCA结合的分子基础并确定增加ATPase活性的靶标。在AIM 2中,将研究使用Ca2+信号传导和磷酸化的细胞模型来恢复正常心脏功能的增强SERCA吸收的影响,包括CAMKII和β-肾上腺素能刺激的影响。在短期内,这些目标的成功完成将通过调整PLB相互作用来洞悉SERCA的精确控制,从而有可能产生小分子靶标,以治疗糖尿病性心肌病。从长远来看,通常,对功能失调的钙调节的分子和细胞洞察力提供了对糖尿病心肌病和心力衰竭的机械洞察力。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Electrostatic channeling in P. falciparum DHFR-TS: Brownian dynamics and Smoluchowski modeling.
- DOI:10.1016/j.bpj.2014.09.039
- 发表时间:2014-11
- 期刊:
- 影响因子:3.4
- 作者:Vincent T. Metzger;Changsun Eun;Peter M. Kekenes-Huskey;G. Huber;J. A. McCammon
- 通讯作者:Vincent T. Metzger;Changsun Eun;Peter M. Kekenes-Huskey;G. Huber;J. A. McCammon
Computational modeling of subcellular transport and signaling.
- DOI:10.1016/j.sbi.2014.01.006
- 发表时间:2014-04
- 期刊:
- 影响因子:6.8
- 作者:Hake J;Kekenes-Huskey PM;McCulloch AD
- 通讯作者:McCulloch AD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Michael Kekenes-Huskey其他文献
Peter Michael Kekenes-Huskey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Michael Kekenes-Huskey', 18)}}的其他基金
Probing macrophage cell nucleotide sensing and calcium signaling through computation
通过计算探测巨噬细胞核苷酸传感和钙信号传导
- 批准号:
10552460 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
PROBING CELLULAR INTRACELLULAR CALCIUM SIGNALING AND SENSING THROUGH COMPUTATION
通过计算探测细胞内钙信号传导和传感
- 批准号:
9982032 - 财政年份:2017
- 资助金额:
$ 4.39万 - 项目类别:
PROBING CELLULAR INTRACELLULAR CALCIUM SIGNALING AND SENSING THROUGH COMPUTATION
通过计算探测细胞内钙信号传导和传感
- 批准号:
10222716 - 财政年份:2017
- 资助金额:
$ 4.39万 - 项目类别:
相似国自然基金
肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
- 批准号:82371024
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
β2肾上腺素能受体基因多态性Arg16Gly影响慢性心衰预后及 β受体阻滞剂疗效的机制研究
- 批准号:81800356
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
β-受体拮抗剂对曲妥珠单抗的增效作用及其机制研究
- 批准号:81773258
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
β2肾上腺素能受体激动剂通过cAMP/PKA通路调控MSCs旁分泌在急性肺损伤修复中的作用和机制
- 批准号:81500058
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
选择性β1肾上腺素能受体阻断剂抗骨质疏松的作用及机理研究
- 批准号:81300710
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
AKAP-dependent regulation of Cardiac SR Ca handling
心脏 SR Ca 处理的 AKAP 依赖性调节
- 批准号:
9910438 - 财政年份:2017
- 资助金额:
$ 4.39万 - 项目类别: